{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:50:37Z","timestamp":1769151037394,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jchromb.2021.122867","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T19:24:34Z","timestamp":1626895474000},"page":"122867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Multi-analyte LC-MS\/MS quantification of 38 antipsychotics and metabolites in plasma: Method validation & application to routine analyses"],"prefix":"10.1016","volume":"1179","author":[{"given":"Maarten","family":"Degreef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor M.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristof E.K.","family":"Maudens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander L.N.","family":"van Nuijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2021.122867_b0005","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.4088\/JCP.16r10832","article-title":"Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: A meta-analysis","volume":"78","author":"Carbon","year":"2017","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.jchromb.2021.122867_b0010","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00228-017-2406-0","article-title":"Antipsychotics use: 2006\u20132013 trends in prevalence and incidence and characterization of users","volume":"74","author":"Montastruc","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2021.122867_b0015","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","article-title":"Off-label prescribing of antipsychotics in adults, children and elderly individuals: A systematic review of recent prescription trends","volume":"21","author":"Carton","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jchromb.2021.122867_b0020","first-page":"329","article-title":"Het gebruik van antipsychotica bij kinderen en jongeren in Belgi\u00eb, 2005\u20132014","volume":"59","author":"Deboosere","year":"2017","journal-title":"Tijdschr. Psychiatr."},{"key":"10.1016\/j.jchromb.2021.122867_b0025","doi-asserted-by":"crossref","DOI":"10.1017\/S2045796020000293","article-title":"Use of antipsychotics in children and adolescents: A picture from the ARITMO population-based European cohort study","author":"Kaguelidou","year":"2020","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.jchromb.2021.122867_b0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology : Update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry."},{"key":"10.1016\/j.jchromb.2021.122867_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.109914","article-title":"Prevalence of therapeutic drugs in blood of drivers involved in traffic crashes in the area of Bologna, Italy","volume":"302","author":"Pelletti","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jchromb.2021.122867_b0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.chroma.2012.12.071","article-title":"Fast quantification of ten psychotropic drugs and metabolites in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring","volume":"1292","author":"Ansermot","year":"2013","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jchromb.2021.122867_b0045","doi-asserted-by":"crossref","first-page":"122129","DOI":"10.1016\/j.jchromb.2020.122129","article-title":"A simple and rapid LC-MS\/MS method for the simultaneous determination of eight antipsychotics in human serum, and its application to therapeutic drug monitoring","volume":"1147","author":"Cao","year":"2020","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2021.122867_b0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpba.2013.07.041","article-title":"Quantification of typical antipsychotics in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring","volume":"88","author":"Gradinaru","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2021.122867_b0055","article-title":"An UHPLC-MS-MS method for the determination of 84 drugs of abuse and pharmaceuticals in blood","author":"Orfanidis","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122867_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FTD.0000000000000197","article-title":"Simple and accurate quantitative analysis of sixteen antipsychotics and antidepressants in human plasma by ultrafast high-performance liquid chromatography\/tandem mass spectrometry","volume":"37","author":"Wang","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2021.122867_b0065","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/dta.1923","article-title":"Development and validation of a multi-analyte LC-MS\/MS approach for quantification of neuroleptics in whole blood, plasma, and serum","volume":"8","author":"Montenarh","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jchromb.2021.122867_b0070","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/jat\/bkaa100","article-title":"Identification and quantification of antipsychotics in blood samples by LC\u2013MS-MS: Case reports and data from three years of routine analysis","volume":"44","author":"Proen\u00e7a","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122867_b0075","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jms.1783","article-title":"Identification and quantification of 30 antipsychotics in blood using LC-MS\/MS","volume":"45","author":"Saar","year":"2010","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2021.122867_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2014.08.039","article-title":"Simple and sensitive screening and quantitative determination of 88 psychoactive drugs and their metabolites in blood through LC\u2013MS\/MS: Application on postmortem samples","volume":"970","author":"Sempio","year":"2014","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jchromb.2021.122867_b0085","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00216-011-5187-9","article-title":"Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs","volume":"401","author":"Remane","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2021.122867_b0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2013.11.024","article-title":"High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography\u2013tandem mass spectrometry","volume":"429","author":"Patteet","year":"2014","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.jchromb.2021.122867_b0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cca.2018.06.047","article-title":"Validation of a simple, fast liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of 40 antidepressant drugs or their metabolites in plasma","volume":"485","author":"Degreef","year":"2018","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.jchromb.2021.122867_b0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jat\/bkaa059","article-title":"Quantification of 54 Benzodiazepines and Z-Drugs, Including 20 Designer Ones, in Plasma","volume":"45","author":"Degreef","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122867_b0105","series-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt","year":"2017"},{"key":"10.1016\/j.jchromb.2021.122867_b0110","first-page":"447","article-title":"Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics","volume":"58","author":"Schulz","year":"2003","journal-title":"Pharmazie."},{"key":"10.1016\/j.jchromb.2021.122867_b0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0379-0738(01)00483-2","article-title":"Drug and chemical blood-level data 2001.pdf","volume":"122","author":"Winek","year":"2001","journal-title":"Forensic Sci Int."},{"key":"10.1016\/j.jchromb.2021.122867_b0120","unstructured":"European Medicines Agency, Guideline on bioanalytical method validation, 44 (2011) 1\u201323. doi:EMEA\/CHMP\/EWP\/192217\/2009."},{"key":"10.1016\/j.jchromb.2021.122867_b0125","article-title":"A dilute and shoot LC-MS\/MS method for antipsychotics in urine","author":"Feng","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122867_b0130","doi-asserted-by":"crossref","DOI":"10.1017\/S2045796021000159","article-title":"Use of antipsychotics in Denmark 1997\u20132018: A nation-wide drug utilisation study with focus on off-label use and associated diagnoses","author":"H\u00f8jlund","year":"2021","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.jchromb.2021.122867_b0135","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bcp.12955","article-title":"Prescribing pattern of antipsychotic drugs during the years 1996\u20132010: a population-based database study in Europe with a focus on torsadogenic drugs","author":"Oteri","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2021.122867_b0140","article-title":"Forskrivning av antipsykotika til hjemmeboende eldre 2006\u201318","volume":"139","author":"Tveito","year":"2019","journal-title":"Tidsskr. Den Nor. Laegeforening."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221003482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221003482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:08:12Z","timestamp":1761606492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023221003482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":28,"alternative-id":["S1570023221003482"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122867","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-analyte LC-MS\/MS quantification of 38 antipsychotics and metabolites in plasma: Method validation & application to routine analyses","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122867"}}